LABA/LAMA versus LABA/ICS fixed-dose combinations in the prevention of COPD exacerbations: a modeling analysis of literature aggregate data

被引：0
|
作者：
Yiwen Gong
Zichao Sui
Yinghua Lv
Qingshan Zheng
Lujin Li
机构：
[1] University of Traditional Chinese Medicine,Center for Drug Clinical Evaluation Shanghai
来源：
European Journal of Clinical Pharmacology | 2023年 / 79卷
关键词：
Chronic obstructive pulmonary disease; LABA/LAMA fixed-dose combinations; LABA/ICS fixed-dose combinations; COPD exacerbations; Model-based meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1321 / 1332
页数：11
相关论文
共 50 条
  • [41] Clinical course of asthma control and adherence in patients treated with fixed combinations of ICS, LABA & LAMA in Germany - AdditionNIS
    Woehrle, H.
    Bushart, G.
    PNEUMOLOGIE, 2024, 78 : S74 - S74
  • [42] Adding a LAMA to ICS/LABA Therapy A Meta-analysis of Triple Combination Therapy in COPD
    Calzetta, Luigino
    Cazzola, Mario
    Matera, Maria Gabriella
    Rogliani, Paola
    CHEST, 2019, 155 (04) : 758 - 770
  • [43] Effects Of Roflumilast In COPD Patients Receiving Ics/laba Fixed-Dose Combination: Rationale And Design Of A Prospective Randomized Controlled Trial
    Rennard, S. I.
    Martinez, F. J.
    Sethi, S.
    Zhu, H.
    Haberman, R.
    Zovko, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [44] COST AND DRUG UTILIZATION TRENDS IN INHALED CORTICOSTEROIDS/LONG-ACTING BETA AGONISTS (ICS/LABA) FIXED-DOSE COMBINATIONS IN SPAIN
    Collar, J. M.
    Colas, C.
    VALUE IN HEALTH, 2018, 21 : S409 - S409
  • [45] Stepping down from triple inhaled therapy to a LABA/LAMA fixed-dose combination: Data from the German real-life DACCORD COPD cohort
    Vogelmeier, F. C.
    Worth, H.
    Buhl, R.
    Criee, P. C.
    Gueckel, E.
    Kardos, P.
    PNEUMOLOGIE, 2022, 76 : S70 - S70
  • [46] Treatment with LABA versus LAMA for stable COPD: a systematic review and meta-analysis
    Koarai, Akira
    Sugiura, Hisatoshi
    Yamada, Mitsuhiro
    Ichikawa, Tomohiro
    Fujino, Naoya
    Kawayama, Tomotaka
    Ichinose, Masakazu
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [47] Treatment with LABA versus LAMA for stable COPD: a systematic review and meta-analysis
    Akira Koarai
    Hisatoshi Sugiura
    Mitsuhiro Yamada
    Tomohiro Ichikawa
    Naoya Fujino
    Tomotaka Kawayama
    Masakazu Ichinose
    BMC Pulmonary Medicine, 20
  • [48] Stepping Down from Triple Inhaled Therapy to a LABA/LAMA Fixed-Dose Combination: Data from the German Real-Life DACCORD COPD Cohort
    Vogelmeier, C.
    Worth, H.
    Buhl, R.
    Criee, C.
    Gueckel, E.
    Kardos, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [49] A Prospective Non-Interventional Study in COPD Patients That Evolve to Fixed LABA/LAMA/ICS Triple Therapy (TRIVOLVE)
    Brusselle, G. G.
    Himpe, U.
    Haerens, M.
    Fievez, P.
    Leduc, D.
    Peche, R.
    Vanderhelst, E.
    Rommes, B.
    Geelissen, S.
    Gesquiere, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [50] COST-EFFECTIVENESS OF THE FIXED-DOSE COMBINATION TIOTROPIUM plus OLODATEROL VERSUS TIOTROPIUM AND LABA/ICS IN FINLAND, SWEDEN AND THE NETHERLANDS
    Hoogendoorn, M.
    Ramos, Corro, I
    Soulard, S.
    Cook, J.
    Soini, E.
    Fast, T.
    Rutten-van Molken, M.
    VALUE IN HEALTH, 2020, 23 : S722 - S722
12345